• Image of Promacta medication Image of Promacta medication
    • ELTROMBOPAG OLAMINE (Generic for PROMACTA)

ELTROMBOPAG (el TROM boe pag) treats low levels of platelets in your body caused by liver disease or immune thrombocytopenia (ITP). It works by increasing the amount of platelets in your blood. This lowers the risk of bleeding. It may also be used to treat aplastic anemia, a condition that occurs when your body does not make enough new blood cells.


ELTROMBOPAG OLAMINE (Generic for PROMACTA) Lifestyle Interactions

  • Eltrombopag Olamine 50mg, Oral tablet

    Interaction: food high in calcium
    Severity: Major
    Notes for Consumers: Take Eltrombopag 1 hour before or 4 hours after you have food. Foods high in calcium may decrease the amount of Eltrombopag absorbed by the stomach, which can decrease the effects of Eltrombopag.
    Notes for Professionals: Eltrombopag chelates polyvalent cations (e.g., calcium, aluminum, and magnesium) in food. Systemic exposure to eltrombopag may be decreased when it is coadministered with a polyvalent cation-containing product. Eltrombopag should not be taken within 4 hours of any oral products containing polyvalent cations, such as calcium salts.
  • Eltrombopag Olamine 50mg, Oral tablet

    Interaction: Foods High in Iron
    Severity: Major
    Notes for Consumers: Take Eltrombopag 1 hour before or 4 hours after you have food. Foods high in iron may decrease the amount of Eltrombopag absorbed by the stomach, which can decrease the effects of Eltrombopag.
    Notes for Professionals: Eltrombopag chelates polyvalent cations (e.g., calcium, aluminum, and magnesium) in food. Systemic exposure to eltrombopag may be decreased when it is coadministered with a polyvalent cation-containing product. Eltrombopag should not be taken within 4 hours of any oral products containing polyvalent cations, such as aluminum salts, (like aluminum hydroxide), calcium salts, (including calcium carbonate), and magnesium salts.

DISCLAIMER: This drug information content is provided for informational purposes only and is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Patients should always consult their physician with any questions regarding a medical condition and to obtain medical advice and treatment. Drug information is sourced from GSDD (Gold Standard Drug Database ) provided by Elsevier.